About Us
Founded in 1944, the American Committee for the Weizmann Institute of Science develops philanthropic support for the Weizmann Institute in Israel, and advances its mission of science for the benefit of humanity.
As The Jerusalem Post reports, Phytolon – the company based on discoveries by Prof. Asaph Aharoni – has received funding for development of its natural, non-synthetic food coloring.
September 20, 2020
The New Yorker covers the incredible potential of designer proteins – including the work of Prof. Sarel Fleishman.
September 18, 2020
The Jerusalem Post reports on the Institute’s recent discovery of a large variety of antiviral substances that have the potential to help fighting viral diseases.
September 17, 2020
REHOVOT, ISRAEL—September 16, 2020—By tracking the evolution of what may be our oldest means of fighting off viral infection, a group at the Weizmann Institute of Science has uncovered a gold mine of antiviral substances that may lead to the development of highly effective antiviral drugs.
September 16, 2020
The Times of Israel covers Dr. Noam Stern-Ginossar’s recent discovery of proteins produced by people who have had COVID, and which could pave the way to new drugs.
September 15, 2020
REHOVOT, ISRAEL—September 13, 2020—A Memorandum of Understanding (MoU) between the Weizmann Institute of Science in Israel and the Mohamed bin Zayed University of Artificial Intelligence (MBZUAI) in the United Arab Emirates was signed on September 12.
September 13, 2020
Prof. Michal Schwartz’s Alzheimer’s therapy, developed by ImmunoBrain Checkpoint, is entering Phase I trials and could change – even stop – the disease’s course, reports The Jerusalem Post.
September 10, 2020
REHOVOT, ISRAEL—September 9, 2020—“Contact tracing” inside infected cells is providing new clues into the workings of SARS-CoV-2, the virus that causes COVID-19. A research team at the Weizmann Institute of Science and the Israel Institute for Biological Research...
September 09, 2020
Blood cancers are far too common, comprising almost 10% of new cancer diagnoses each year in the U.S. Almost every 10 minutes, an American succumbs to a blood cancer. Unfortunately, many of these are children.
That's why the Weizmann Institute of Science’s researchers are conducting innovative studies and taking novel approaches to blood cancers. September is Blood Cancer Awareness Month, and we’d like to share with you some of Weizmann’s current investigations.
September 2020
©2021 American Committee for the Weizmann Institute of Science